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ScienceDirectCohesin is an evolutionarily conserved large ring-like multi-
subunit protein structure that can encircle DNA. Cohesin
affects many processes that occur on chromosomes such as
segregation, DNA replication, double-strand break repair,
condensation, chromosome organization, and gene
expression. Mutations in the genes that encode cohesin and its
regulators cause human developmental disorders and cancer.
Several mouse models have been established with the aim of
understanding the cohesin mediated processes that are
disrupted in these diseases. Mouse models support the idea
that cohesin is essential for cell division, but partial loss of
function can alter gene expression, DNA replication and repair,
gametogenesis, and nuclear organization.
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Introduction: cohesin is regulated over the cell
cycle
Chromosomes have to duplicate and segregate each cell
cycle. Accurate segregation requires opposition to the
separation force of the microtubules. This cohesion be-
tween sister chromatids is provided by the cohesin com-
plex. Genes encoding the subunits of this eukaryotic
complex were originally discovered in yeast mutants that
displayed premature separation of sister chromatids. How-
ever, cohesin is evolutionarily related to the bacterial struc-
tural maintenance of chromosomes (SMC) complex, which
is also important for genome transmission. SMC complexes
exist in all eukaryotes with an increasing number of possible
complexes and specializations over evolutionary time [1].
Cohesin is important for many chromosomal processes,
including chromosome segregation, DNA replication,
double-strand break repair, condensation, chromosomewww.sciencedirect.com organization, and gene expression [2–4]. Mutations in the
genes that encode the subunits of the cohesin complex
and associated factors cause human developmental dis-
orders such as Cornelia de Lange syndrome (CdLS) [5,6]
and Roberts syndrome (RBS) [7] as well as cancer [8–10].
The cohesin complex consists of four subunits that are
arranged in a ring shaped structure. Two of the subunits
are SMC proteins, SMC1 and SMC3; one is a kleisin
(closure) subunit, RAD21; and one is stromal antigen (SA;
also known as STAG) (Figure 1). With the exception of
SMC3, all other subunits exist in at least two forms, with
one or more being meiosis specific (Table 1). The SMC
proteins contain globular domains at their N and C
termini and in the middle. In between globular domains
there is a long coiled-coil region. The N and C termini
come together to form a ‘head’ domain, which contains a
ABC-type ATPase [11]. The middle globular domain
forms a ‘hinge’ domain, which interacts with the hinge
domain of the other SMC protein. The N terminus of the
kleisin subunit binds to the SMC3 head domain and the C
terminus binds to the SMC1 head domain [12]. The SA
subunit associates with the complex via the kleisin sub-
unit. The integrity of the ring structure is important for
the stable association of cohesin with chromatin.
The association of the cohesin complex with chromatin
is regulated over the cell cycle. Cohesin loading occurs
in G1 phase (yeast) or telophase (vertebrates) with the
help of the NIPBL-MAU2 heterodimer (Figure 2) and
ATP hydrolysis [13]. Recent biochemical reconstitu-
tion of the loading reaction showed that cohesin has an
intrinsic ability to load onto naked DNA but loading is
more efficient in the presence of NIPBL [14]. MAU-2 is
not required in vitro for cohesin loading but is essential
in vivo. Cohesin encircles two sister chromatids during
S phase, but the details leading to this state are murky.
This cohesion ‘establishment’ requires acetylation of
the SMC3 head domain by acetyl transferases ESCO1
and ESCO2 [15]. Two proteins, wings apart-like pro-
tein (WAPL) and PDS5 (PDS5A and PDS5B) bind with
chromatin associated cohesin and promote cohesin
unloading, especially in the absence of acetylation
[16]. In vertebrates binding of sororin to PDS5 dis-
places WAPL and prevents cohesin unloading [17].
Cohesion destruction occurs in at least two cell cycle
coupled waves. Cohesin is first removed from chromosome
arms during prophase and then from the centromeric
regions to enable the transition from metaphase to ana-Current Opinion in Cell Biology 2015, 37:9–17
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Structure of the cohesin complex. In somatic cells, the cohesin ring is
composed of SMC1a, SMC3, RAD21, and SA1 or SA2. In germ cells,
the cohesin ring can also contain substitutions with SMC1b, REC8,
RAD21L, and SA3. The number of complexes that exist during
mammalian meiosis is currently unclear. SMC proteins are long
polypeptides that fold back on themselves to form a coiled-coil
domain with a hinge domain at one end and an ATPase domain at the
other. SMC1 and SMC3 (blue) together form a V-shaped structure by
interaction of their hinge domains. The N-terminus and C-terminus of
RAD21 (green) interacts with SMC3 and SMC1 respectively. The SA
subunit (purple) interacts with RAD21.Source: Adapted from Ref. [74].
Table 1
Cohesin subunits and regulators
Subunits S. cerevisiae Ma
Structural maintenance of chromosomes (SMC) Smc1 Sm
Smc3 Sm
Sm
a-Kleisin Scc1 Rad
Rad
Rec8 Rec
Stromalin Scc3 SA
SA
SA
Loading Scc2 Nip
Scc4 Ma
Establishment Eco1 Esc
Esc
Maintenance Pds5 Pds
Pds
Wpl1 Wa
Sor
Pp2A Pp2
Sgo
Sgo1 Sgo
Dissolution Esp1 Sep
Pds1 Sec
Cdc5 Plk
Aur
Cd
Hos1 Hd
Current Opinion in Cell Biology 2015, 37:9–17 phase [18]. In the prophase pathway, CDK1 and AURKB
phosphorylate sororin which leads to its dissociation from
PDS5 [19] so that WAPL can unload cohesin. PLK1 can
phosphorylate the SA2 subunit of cohesin, which also
facilitates cohesin removal [20]. In prophase, centromeric
cohesin is protected by shugoshin 1 (SGO1) and protein
phosphatase 2A (PP2A). SGO1-PP2A antagonises sororin
phosphorylation and protects it from removal [21]. To
initiate anaphase, activation of the anaphase promoting
complex/cyclosome (APC/C) leads to securin degradation
and separase activation. The activated separase cleaves the
kleisin subunit and allows for separation of the sister
chromatids [22].
In this article we will (1) summarize the phenotypes of
mice with mutations that affect cohesin and its regulators
and (2) examine what is known about how mutations in
the genes that encode these proteins cause human de-
velopmental disorders and cancer. Many of these diseases
appear to be caused by partial loss of function; complete
loss of function is not compatible with life. With partial
loss of function, there is evidence that DNA repair and
replication, chromosome organization, and gene expres-
sion are disrupted. Many reviews have been written
describing the regulation and structure of the cohesinmmals Null phenotype in mouse Human syndromes
c1a CdLS, Cancer
c3 Embryonic lethal (E14.5) [25] CdLS, Cancer
c1b Male and female sterile [33,34]
21 Early embryonic lethal [26] CdLS, Cancer
21L Male sterile [35]
8 Male and female sterile [36]
1 Embryonic lethal (E11.5) [30] Cancer
2 Cancer
3
bl Early embryonic lethal [38] CdLS
u2 Early embryonic lethal [40]
o1
o2 Lethal at 8 cell stage [43] RBS
5A Growth retardation [44]
5B Growth retardation [45] Cancer
pl Embryonic lethal [16]
orin
A Embryonic lethal [47]
1 Embryonic lethal [46] Cancer
2 Male and female sterile [48]
arase Cell cycle arrest at blastocyst [53]
urin Viable [55] Cancer
1 Lethal at 8 cell stage [52] Cancer
oraB Embryonic lethal [49,50]
k1 Embryonic lethal [51]
ac8 Perinatal lethal [58] CdLS
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Cell cycle dependent cohesin loading and unloading. Cohesin (blue) is loaded onto the chromosome in late telophase by the NIPBL-MAU2
heterodimer. Binding of PDS5-WAPL through RAD21 and SA1/2 promotes cohesin unloading. ESCO1 and ESCO2 acetylate SMC3 to stabilize the
cohesin–DNA association. Sororin is recruited to PDS5 to antagonise WAPL function. During prophase, Aurora kinase B and CDK1 phosphorylates
sororin and facilitate its removal. Polo-like kinase 1 phosphorylates the SA subunit to facilitate its removal cohesin from chromosome arms. During
prophase, centromeric cohesin is protected by the binding of shugoshin and PP2A. During anaphase, the APC/C complex activates separase
which cleaves RAD21 to release centromeric cohesin to allow sister chromatid separation. SMC3 is recycled by deacetylation with HDAC8.
Source: Adapted from Ref. [74].complex. For more information on these topics the reader
is referred to Nasmyth et al. and Xiong et al. [1,23].
Phenotypes of mice with mutations in cohesin
and associated factors are consistent with
defects in many different cellular processes
With the discovery of mouse embryonic stem cells and
the ease of gene manipulation in these cells, mouse has
developed into a premier mammalian model system for
genetic research in the last few decades [24]. Yeasts, C.
elegans and Drosophila are excellent models for cell cycle
regulation and many developmental processes. But mice
are often a better model for understanding reproductive
and cell type specific processes because of the close
genetic and physiological similarities to humans. Mice
can be maintained at relatively low cost and multiply
quickly. Many different cohesin-associated genes have
been mutated in mice. The phenotypes are summarized
in Table 1.
Cohesin subunits are indispensable for early embryonic
development
Homozygous deletions of genes encoding the mitotic
cohesin subunits are early embryonic lethal while hetero-
zygous knockout mice have variable phenotypes. Muta-
tions in one copy of RAD21, SMC1a or SMC3 have all been
associated with human developmental syndromes knownwww.sciencedirect.com as cohesinopathies. Smc3 homozygous mutant mice die
prior to E14.5 [25]. Smc1a deficient mice have not been
reported but would also presumably show embryonic
lethality. Some lethality was also observed in Smc3 het-
erozygous mice. The live heterozygous mice showed
reduced body weight, some craniofacial defects, and an
increased number of helper and cytotoxic T-cells, sug-
gesting cell and tissue specific developmental processes
are being affected with haploinsufficiency.
Rad21 homozygous knockout mice die by E8.5 [26].
Rad21 heterozygous cells are impaired in homologous
recombination and heterozygous mice are more sensitive
to whole body irradiation suggesting DNA repair is com-
promised. Heterozygous Rad21 MEFs show increased
aneuploidy in culture. The conditional knockout of
Rad21 in non-cycling thymoctes suggests a clear role of
cohesin in gene expression regulation [27].
The fourth cohesin subunit, SA, has three version; SA1,
SA2, and SA3 [28,29]. Two different cohesin complexes
can co-exist in somatic vertebrate cells each with SMC1a,
SMC3 and RAD21 and either SA1 or SA2. SA1 null mice
die by E11.5 while heterozygous mice have a shortened
life span and early onset of tumorigenesis [30]. SA1 null
embryonic fibroblasts show reduced cell proliferation and
enhanced aneuploidy. The aneuploidy is not due to aCurrent Opinion in Cell Biology 2015, 37:9–17
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to defective telomere replication. Cohesin is also lost from
promoters and CTCF sites, consistent with a role for SA1-
cohesin in developmental gene expression programs [31].
The late lethality of SA1 null mice and establishment of
mouse embryonic fibroblasts (MEFs) from null embryos
suggests that there is a compensatory response from SA2.
Mice lacking SA2 have not been reported, although
cohesin complexes with this subunit may be particularly
important for centromeric cohesion [32], suggesting SA2
deletion would be lethal once maternal load is expended.
In summary, homozygous knockout of a gene encoding a
unique somatic cohesin subunit is lethal in mice. Presumably
this would lead to significant defects in chromosome segre-
gation and rampant aneuploidy that would not be compatible
with life. In the heterozygous state many different processes
appear to be affected, including gene expression in devel-
opmental programs, DNA repair and replication.
Meiosis-specific cohesin genes are essential for fertility
There are meiosis specific versions of several cohesin
subunits, including REC8 (RAD21), RAD21L, SA3, and
SMC1b (SMC1). Homozygous deletion of the genes
encoding these proteins reduces fertility. Smc1b defi-
cient mice are healthy with normal mating behaviour
but are sterile [33,34]. Male meiosis is blocked at the
pachytene stage with unstable crossovers, whereas fe-
male meiosis continues up to metaphase II with a high
rate of chromosome mis-segregation due to premature
loss of cohesin. Two paralogs of Rad21, Rec8 and Rad21L,
are meiosis specific in mammals. The knockout of
Rad21L, like Smc1b, shows gender specific phenotypes.
Males are sterile due to defective synapsis of homologous
chromosome at meiotic prophase I which leads to arrest
at zygotene. However, females are fertile and develop
age dependent sterility due to a reduction in the initial
number of oocytes [35]. SA3 is another meiosis-specific
subunit, but a knockout has not been reported. Unlike
the somatic cell specific cohesin gene knockouts, meio-
sis-specific cohesin gene knockouts do not display hap-
loinsufficiency but sometimes show gender specific
phenotypes.
The other meiosis specific kleisin, REC8, is essential for
mammalian meiosis and null mice are sterile [36]. In the
absence of REC8, pairing of homologous chromosome
occurs normally but synapsis occurs between sister
chromatids. Therefore, REC8 normally guides synapsis
between homologous chromosomes. Interestingly, Rec8
null mice displayed in utero and postnatal growth retar-
dation, suggesting a role for REC8 in somatic cell
development also [37]. All of the meiosis specific cohe-
sin gene knockout mice have defects in fertility, consis-
tent with critical roles for these protein complexes in the
meiotic chromosome divisions.Current Opinion in Cell Biology 2015, 37:9–17 Cohesion is established is S phase, and S phase in mam-
malian oocytes occurs in utero. Meiotic cohesion therefore
has to be maintained until the oocyte completes meiotic
divisions which could be months later in mice and dec-
ades later in humans. Loss of meiotic cohesion is thought
to contribute to the increase in aneuploidy associated
with oocytes from older mice and humans. However,
given the fact that other chromosomal processes depend
on cohesin, in the future it will be interesting to explore
whether age-dependent loss of cohesion could compro-
mise additional processes in oocytes.
Cohesin loading and establishment is essential for
mammalian cell viability
The human developmental disorder CdLS is most often
caused by a mutation in one copy of NIPBL. Cohesin is
loaded onto chromatin by the NIPBL-MAU2 heterodi-
mer during telophase. Homozygous knockout of Nipbl is
lethal early in mouse embryogenesis [38]. Heterozygous
mice show defects characteristic of CdLS, including small
body size, craniofacial anomalies, heart defects, micro-
brachycephaly, hearing abnormities and delayed bone
formation. In fact, these phenotypes arise due to a 30%
reduction in mRNA levels of Nipbl, demonstrating that
developmental processes are extremely sensitive to the
dosage. Heterozygous MEFs have robust cohesion all
along chromosomes, with effective DNA repair and
DNA replication [39], suggesting that gene expression
is the main process affected.
Mau2 homozygous knockout is also embryonic lethal [40].
However heterozygous mice are indistinguishable from
wild type mice suggesting either a difference in the role of
NIPBL and MAU2 in gene regulation or a difference in
the importance of dosage. Neural crest specific knockouts
of both Nipbl and Mau2 show defects in craniofacial
development. Interestingly, neural crest specific Mau2
mutants display more severe phenotypes than Nipbl
mutants, suggesting that MAU2 is more essential in these
cells [40], although mutations in Mau2 have not been
associated with CdLS. The developmental abnormalities
that occur with heterozygous deletions in these genes are
best explained by defects in gene expression, consistent
with the proposal that the developmental defects in
CdLS arise from changes in gene expression. These
changes may be due to the disruption of chromatin,
chromatin looping, transcriptional elongation, and other
processes related to gene expression [41].
During DNA replication, the establishment of cohesion
requires acetylation of the SMC3 head domain by ESCO1
and ESCO2 at K105 and K106 [42]. Both copies of ESCO2
are non-functional in the human developmental disorder
RBS. Esco1 knockout mice have not been reported. Esco2
knockout mice die at the eight cell stage before implan-
tation [43]. Deletion of Esco2 reduces SMC3 acetylation
and decreases chromatin associated sororin throughout
the genome. ESCO2 is essential for cohesin acetylation inwww.sciencedirect.com
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essary for proper distribution of cohesin on mitotic chro-
mosomes. The early lethality in the Esco2 knockout mice
suggests that there is no compensation from ESCO1 (or
other acetyltransferases) in mice, as there might be in
humans. The very early lethality precludes the use of this
mouse model for understanding the developmental phe-
notypes associated with RBS, but a heterozygous or
conditional allele could be useful.
Cohesin maintenance factors are crucial for embryonic
development
Consistent with PDS5, WAPL, PP2A and shugoshin
acting as maintenance factors for cohesion, complete loss
of function is not tolerated. Because there are two Pds5
genes in mammals and cohesion relies on both Pds5A and
Pds5B, each one can be deleted separately, but the double
knockout is early embryonic lethal [44], suggesting that
PDS5A and B have partially overlapping functions. Single
Pds5 knockout mice show phenotypes resembling some
of the developmental defects associated with CdLS, such
as growth retardation, congenital heart defects, cleft
palate, and skeletal patterning defects [44,45]. However,
mutations in PDS5 have not been reported to cause
CdLS. Interestingly, similar to Nipbl heterozygous MEFs,
Pds5B null MEFs do not show cohesion defects. The
developmental abnormalities associated with Pds5A and
Pds5B null mice suggest an important role in gene ex-
pression while the nucleolar localization of PDS5B sug-
gests an additional role in nucleolar function.
Homozygous knockout of the gene encoding the PDS5
interacting protein WAPL is embryonic lethal [16]. De-
letion of Wapl causes premature condensation of chromo-
somes during interphase due to increased stability of the
cohesin-chromosome association. WAPL is essential for
the proper release of cohesin from DNA. The action of
WAPL is antagonised by sororin, which has not been
mutated in mice.
SGO1 and SGO2, known as shugoshins, help to protect
centromeric cohesion during the prophase dissociation of
arm cohesin. Complete loss of SGO1 leads to early embry-
onic lethality [46]. Sgo1 heterozygous mice are viable and
fertile. Interestingly, after exposure to a colon carcinogen,
these mice have accelerated tumorigenesis and chromo-
some instability, suggesting a defect in DNA damage
repair. The heterozygous Sgo1 MEFs show missegregation
of chromosomes and formation of extra centrosomal foci
that contribute to genome instability. Along with shu-
goshin, PP2A protects centromeric cohesin. Knockout of
the catalytic subunit is embryonic lethal after implantation
[47]; chromosomal phenotypes were not reported.
In contrast to Sgo1, homozygous knockout of Sgo2 results
in a viable mouse [48]. Sgo2 deletion did not cause any
chromosome missegregation in MEFs or other somaticwww.sciencedirect.com tissues. However, both male and female Sgo2 null mice
are sterile. Thus, SGO2 appears to play a meiosis specific
role in protecting centromeric cohesion; loss of SGO2
promotes premature release of the meiosis-specific REC8
cohesin complex prior to anaphase I. The Sgo2 mutant
demonstrates the essential role for meiosis-specific cohe-
sin regulators in the meiotic chromosome divisions.
Cohesin dissolution factors are essential for early
embryonic development
Dissolution of cohesion occurs first via the prophase
pathway at chromosome arms and then second at cen-
tromeres to initiate anaphase. During prophase, Aurora B
and CDK1 phosphorylate sororin to release cohesin.
Deletion of Aurkb leads to embryonic lethality and MEFs
show delayed G1/S phase transition and premature mi-
totic exit [49,50]. Cdk1 null mice are embryonic lethal at
the blastocyst stage [51] and CDK1 is essential for cell
proliferation. Plk1 encodes a kinase that phosphorylates
SA2 for cohesin release during prophase dissociation.
Similar to the Esco2 mutant mice, Plk1 homozygous
deletion is lethal at the 8-cell stage [52]; in both cases
this is likely due to the end of maternal load. Interesting-
ly, in contrast to human tumors - where PLK1 was over-
expressed, heterozygous Plk1 mice have a higher
incidence of tumor formation.
To initiate anaphase, separase cleaves centromeric
RAD21 to allow chromosome segregation. Separase de-
letion is lethal at the blastocyst stage [53]. Separase
deficient MEFs show growth retardation and increased
ploidy. During anaphase, APC/C degrades securin to
activate separase and in yeast securin inhibits separase
activity [54]. Surprisingly, securin null mice are viable and
fertile with no overt phenotype [55], suggesting addition-
al mechanisms must regulate separase. In vertebrates
inhibitory phosphorylation on serine 1121 of separase
provides another level of regulation. Interestingly, mice
carrying mutations in separase (S1121A) are infertile [56].
Although these two mechanisms of separase regulation
are redundant in somatic cells, the inhibitory phosphor-
ylation of separase may uniquely affect germ cells.
Following anaphase, cohesin dissociates from chromatin.
Histone deacetylase 8 (HDAC8) deacetylates SMC3 to
allow it to be recycled for the next cell cycle. Mutations in
HDAC8 cause CdLS. Without HDAC8 activity, SMC3
acetylation and chromatin association increases [57].
Homozygous deletion of Hdac8 causes perinatal lethality
in mice due in part to skull instability [58]. Neural crest
cell specific inactivation of Hdac8 leads to CdLS pheno-
types in mice [58]. Both the Hdac8 and Nipbl mutant mice
recapitulate the craniofacial defects associated with
CdLS, likely due in part to defects in neural crest cells.
Future experiments aimed at understanding how cohesin
mutations specifically affect mouse neural crest cellsCurrent Opinion in Cell Biology 2015, 37:9–17
14 Differentiation and diseaseshould help shed light on the role of cohesin in this
important cell type.
Human developmental syndromes and
cancers are associated with mutations in
cohesin
Cornelia de Lange syndrome is caused by mutations in
several different cohesin genes
Cohesinopathies are human developmental syndromes
caused by mutations in cohesin and its regulators. Muta-
tions in cohesin subunits and regulatory factors lead to
developmental disorders such as CdLS [59] and RBS [7]
as well as cancer [8,60]. CdLS affects one individual in
every 10,000 live births while RBS and other cohesino-
pathies are extremely rare. The affected individuals have
craniofacial and limb deformities, hirsutism, gastroesoph-
ageal dysfunction, neurodevelopmental delay [61], and
mild to severe intellectual disability [5]. The majority of
CdLS mutations have been reported in NIPBL (65%),
SMC1a (5%), SMC3 (1-2%), and HDAC8 (5%) [59,62].
Mutations in RAD21 cause a CdLS-like disorder [63].
Together mutations in these five genes account for 75%
of patients with CdLS or CdLS-like phenotypes. In most
cases, the reported mutations are predicted to cause a
partial loss of function or haploinsufficiency. However,
the mutations in the SMC subunits may instead cause
disease by virtue of dominant negative effects on the
cohesin complex.
Mutations in NIPBL associated with severe CdLS are
found throughout the gene and consist mainly of non-
sense, splice site, and frame shift mutations which pro-
duce haploinsufficiency. Missense mutations are more
often associated with a mild CdLS phenotype. The idea
that loss of NIPBL function causes CdLS is supported by
Nipbl +/mice with CdLS phenotypes. This is noteworthy
because many cases of haploinsufficiency in humans are
not well phenocopied in mice. For example, mutation in
one copy of RAD21 causes a mild CdLS-like phenotype
[63] but Rad21+/ mice have no overt developmental
phenotypes.
Recently mutations in HDAC8 have been reported in
CdLS patients and the majority of these mutations cause
loss of HDAC8 activity [6]. Hdac8 homozygous knockout
mice have severe craniofacial defects and small size,
consistent with phenotypes in CdLS. Heterozygous fe-
male mice are born at sub-Mendelian ratios due to
random inactivation of one allele (Hdac8 is encoded on
the X chromosome), again suggesting haploinsufficiency.
Poor growth is a feature shared between Nipbl and Hdac8
mice and CdLS patients. Since this phenotype is clearly
modelled in the mice, the mouse models could be used to
unravel the molecular origins of this phenotype.
All the mutations reported in SMC1a (X-chromosome
encoded) in CdLS are either missense or small in-frameCurrent Opinion in Cell Biology 2015, 37:9–17 deletions, suggesting nonsense mutations are not tolerat-
ed [64]. These mutations have been reported as hemizy-
gous males and heterozygous females, but most of the
cases are females, suggesting that these mutations in
SMC1a could act in a dominant negative manner [64].
Mutations in SMC3 associated with CdLS also suggest a
possible dominant negative mode of action [65]. Smc3+/
mice show a higher mortality rate. Biochemical analysis of
these mutant proteins may provide insight into how they
affect the activity of the complex.
Roberts syndrome is caused by mutations in a cohesin
acetyltransferase
RBS is an autosomal recessive disorder caused by muta-
tion in both copies of ESCO2, resulting in complete loss of
either protein or enzyme activity [66]. The complete loss
of ESCO2 function may be possible since humans have
ESCO1. The affected individuals have pre-natal and
postnatal growth retardation, limb defects, and craniofa-
cial anomalies [67]. ESCO1 mutations are probably not
compatible with life. RBS cells from patients display
aneuploidy, micronuclei, and heterochromatin repulsion
[68].
Results using various model systems suggest ESCO2-
mediated cohesion is important for nucleolar organiza-
tion, rRNA production, and ribosome biogenesis [2,69].
Loss of ESCO2 in mice is lethal in an early stage of
embryo development [43] suggesting it is essential for
cell survival. The difference between human and mice
could be due to (1) the existence of other isoforms of
ESCO2 in humans or (2) the fact that all mouse chromo-
somes are acrocentric. The mouse genome may be more
susceptible to Esco2 mutation since ESCO2 function
appears to be most significant for heterochromatin cohe-
sion on acrocentric chromosomes [67]. ESCO1 and
ESCO2 probably have both overlapping and specific
roles. Their specificity is still not well understood, but
they are differentially regulated [70]. ESCO2, in particu-
lar, is nucleolar [71], consistent with data showing severe
nucleolar dysfunction associated with cells derived from
RBS patients [69,72]. Nucleolar dysfunction appears to
contribute significantly to this disease.
Several types of cancer are caused by mutations in
different cohesin genes
Mutations in NIPBL were initially reported in human
colorectal cancer [8] and later mutations in SA2 were
reported in glioblastoma, melanoma, and acute myeloid
leukemia (AML) [9]. Mutations in other cohesin subunits
such as SA1, SA2, SMC3, RAD21, and SMC1a have been
reported as driver mutations in AML [73]. Interestingly,
the majority of these cancers have normal karyotypes,
suggesting chromosome segregation and aneuploidy are not
driving the cancer. Instead, these results suggest that partial
loss of function affects other chromosomal processes, such
as gene expression, chromosome organization, and DNAwww.sciencedirect.com
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Box 1 Cohesin, mediator (a transcriptional coactivator), and Nipbl
have been shown to interact in mouse embryonic stem cells [76].
This interaction may facilitate gene looping at active genes [41,74].
Furthermore, cohesin has been proposed to maintain embryonic
stem cell pluripotency, although this finding has been debated [77].replication. Cohesin binds to the promoters and enhancers
of highly transcribed genes where it has the possibility to
affect gene expression and chromosome organization [74]
(Box 1), as well as other processes. Glioblastoma cells with
mutations in SA2 are sensitive to PARP (poly-ADP ribose
polymerase) inhibitors, suggesting DNA repair may be an
important process to target in SA2-driven cancers [75]. In
the future, it will be interesting to determine which cohe-
sin-regulated chromosomal processes drive specific cancers
in order to predict and test potential therapies.
Summary
In the last decade tremendous effort has been made to
understand how cohesin contributes to chromosome func-
tion using mouse models. Many of the homozygous
deletions in genes encoding subunits or regulators of
the somatic complex in mice are lethal, but some hetero-
zygous or homozygous mutant mice display features
consistent with human CdLS. Deletion of genes with
different molecular functions produces some overlapping
developmental phenotypes, but also some distinct phe-
notypes, which will be interesting to untangle in future
studies. While the underlying molecular mechanisms
have yet to be fully determined, gene expression and
DNA repair are processes that can clearly be affected.
These findings have already provided useful insights into
the complex molecular etiology of cohesinopathies. Fur-
thermore, meiosis-specific subunits and regulators are
clearly essential for gametogenesis. Future studies taking
advantage of conditional knockouts will provide insights
into the tissue specific roles of cohesin and its regulators
while gene editing will allow for the construction of mice
with specific disease alleles. The development of mouse
models for cohesin-driven cancers will aid our under-
standing of this infant field.
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